Predictive Oncology Refreshes Board with Appointment of Three New Directors

by NASDAQ Market News July 14, 2020

NASDAQ Market News
Click here to email author

SOTIO Announces First Patient Dosed in Part B of Phase 1/1b Study with SO-C101 in Combination with Pembrolizumab in Patients with Solid Tumors

CHF Solutions Continues Physician-Led Webinar Series with Focus on Treatment of Fluid Overload in Pediatric Patients

Ads